What Does ODAC Stand For?

ODAC stands for Oncologic Drugs Advisory Committee

The Oncologic Drugs Advisory Committee (ODAC) is a panel of experts that provides independent advice to the U.S. Food and Drug Administration (FDA) on the evaluation of drugs intended for the treatment of cancer. The committee reviews clinical trial data, assesses the safety and efficacy of oncology therapies, and offers recommendations regarding their approval and use, thus playing a crucial role in the development and regulation of cancer treatments.